GSA Capital Partners’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
AIM
GSA Capital Partners's VCYT Position: Q2 2026 in Review
GSA Capital Partners opened a new position in Veracyte (VCYT) in Q2 2026: 6,430 shares worth $378K. The stake represents 0.02% of the portfolio and ranks #1173 among its holdings. This is a return to the name: GSA Capital Partners previously reported a position in VCYT as recently as Q1 2025.
GSA Capital Partners first reported a position in VCYT in Q4 2016 and has held it in 16 quarters since. The position peaked at $2.19M in Q1 2023. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.
- GSA Capital Partners held 6,430 shares of Veracyte worth $378K as of Q2 2026.
- Veracyte was a new GSA Capital Partners position in Q2 2026.
- Veracyte made up 0.02% of GSA Capital Partners's portfolio in Q2 2026, its #1173 holding.
- GSA Capital Partners first reported a position in Veracyte in Q4 2016 and has held it in 16 quarters since.
- GSA Capital Partners's Veracyte position peaked at $2.19M in Q1 2023.
- 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.
Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.